July 20, 2005Transition Agreement • July 22nd, 2005 • Atherogenics Inc • Pharmaceutical preparations
This letter memorializes our discussions regarding your voluntary retirement from AtheroGenics, Inc. (the "Company") and the transition services that you have agreed to provide in order to ensure a smooth transition. AtheroGenics is entering into this Transition Agreement (“Agreement”), in part, in recognition of the valuable services you have provided to the Company over the last several years.
